Vita Life Sciences Limited (ASX:VLS)
Australia flag Australia · Delayed Price · Currency is AUD
2.520
-0.080 (-3.08%)
At close: Mar 4, 2026

Vita Life Sciences Ratios and Metrics

Millions AUD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1391411119677105
Market Cap Growth
35.02%26.53%16.19%25.14%-26.95%93.88%
Enterprise Value
10611484776289
Last Close Price
2.512.581.901.621.191.62
PE Ratio
13.6813.5112.6810.5610.8112.65
Forward PE
-16.8116.8116.8116.8116.81
PS Ratio
1.491.511.401.311.151.84
PB Ratio
2.482.512.132.212.103.45
P/TBV Ratio
2.472.512.132.212.103.41
P/FCF Ratio
8.778.8918.707.7829.0618.29
P/OCF Ratio
8.468.5818.097.3827.6017.81
EV/Sales Ratio
1.131.221.061.060.931.57
EV/EBITDA Ratio
7.037.836.996.395.667.94
EV/EBIT Ratio
7.548.107.206.535.798.11
EV/FCF Ratio
6.677.1714.106.2923.5715.58
Debt / Equity Ratio
0.040.040.010.010.020.01
Debt / EBITDA Ratio
0.160.160.040.030.050.03
Debt / FCF Ratio
0.150.150.090.030.230.07
Net Debt / Equity Ratio
-0.59-0.59-0.54-0.56-0.41-0.51
Net Debt / EBITDA Ratio
-2.28-2.28-2.34-2.00-1.37-1.38
Net Debt / FCF Ratio
-2.09-2.09-4.71-1.97-5.72-2.71
Asset Turnover
1.211.211.211.321.381.35
Inventory Turnover
2.292.292.332.342.032.42
Quick Ratio
2.042.042.112.211.661.59
Current Ratio
2.732.733.062.982.772.43
Return on Equity (ROE)
19.23%19.23%18.36%22.74%21.94%30.06%
Return on Assets (ROA)
11.37%11.37%11.06%13.30%13.82%16.32%
Return on Invested Capital (ROIC)
44.11%42.98%37.40%42.75%40.39%60.21%
Return on Capital Employed (ROCE)
24.10%24.10%22.20%27.20%29.00%35.80%
Earnings Yield
7.51%7.41%7.89%9.47%9.25%7.91%
FCF Yield
11.40%11.25%5.35%12.86%3.44%5.47%
Dividend Yield
5.38%5.43%5.27%5.55%5.05%3.56%
Payout Ratio
58.26%58.26%58.85%37.08%42.88%34.91%
Buyback Yield / Dilution
-2.27%-2.27%-1.70%-1.30%-1.64%-0.97%
Total Shareholder Return
2.94%3.16%3.57%4.25%3.41%2.59%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.